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 ABSTRACT  
 
       Bacteriorhodopsin, a model system in nanobiotechnology, is a light-sensitive protein found in the 
archaean Halobacterium salinarum and a very identical protein to visual Rhodopsin. The 
modification of biological function of BR and its versatile properties is valuable for technical 
applications including the artificial retina. These photoactive elements of native and particular 
mutants of bacteriorhodopsin make protein films, used in artificial retinal implants, to treat some 
retinal diseases and disorders. The two major reasons of retinal photoreceptor cell deterioration are 
Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP). As in vitro culture of 
Halobacterium is very difficult, and isolation procedure is much time consuming and usually 
inefficient, so genetic construction of protein is essential. Here, we have produced two types of 
bacteriorhodopsin, a native and a mutant BR (D85E) and studied their opto-electric responses with 
respect to wavelength and absorption properties. They are prerequisite for designing artificial retina 
(sensors) based on biomolecules. Therefore, the new promising technology soon will conceivably 
eradicate the blindness. 
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INTRODUCTION 
     Microelectronics structures are common in 
artificial vision systems. Biomimetic 
technologies are successful systems inspired 
by nature. So different architectures have 
been evolved for processing visual 
information. As a result, some 
microelectronics can be substituted by 
functional biomolecules such as 
bacteriorhodopsin [1]. The potential clinical 
application of BR is for treatment of blindness 
caused by the death of rod and cone 
photoreceptors.  
    Nowadays genetic engineering is a popular 
tool for producing and modifying biological 
macromolecules to function in non-native 
environments and turning it into an 
evolutionary optimized biomaterial [2, 3]. In 
vitro culture of these bacteria is very difficult, 
and isolation procedure is much time 
consuming and usually inefficient, genetic 
production of protein can be helpful. 
Therefore, the aim of this research is to study 
the photochemical properties and to produce 
bacteriorhodopsin and its mutant variant 
D85E, by site-directed mutagenesis, that can 
be used in construction of bioelectronics 
devices, especially in artificial 
retina. Modification of bacteriorhodopsin 
comprises the replacement of key amino acids 
in the protein sequence either by site-directed, 
semi-random, or site-specific saturation 
mutagenesis [2]. 
     Eye photoreceptor cells are classified to 
rod cells and cone cells. Cone cells include 
photo pigments that are essential for color 
vision, and need tens to hundreds of photons 
to become active. Rod cells enclose a photo 
pigment, Rhodopsin, which is greatly 
sensitive to light, so it allows vision under 
dim light circumstances. A rod cell (Figure 1) 
is sensitive enough to become active by a 
single photon of light [5]. 
 
Figure 1. Organization of Rhodopsin inside a Rod Cell. 
[18] 




     Upon illumination, Rhodopsin, the 
photoreceptive pigment of rod cells, will be 
activated and undergoes a conformational 
change. Rhodopsin apoprotein is a seven 
alpha-helical transmembrane protein called 
opsin, covalently bound to a chromophore 
(retinal a prosthetic group and a derivative of 
vitamin A) as shown in Figure 2. Non-active 
retinal (before exposing to light) is in the 11-
cis form, upon light absorption, retinal 
undergoes a conformational change to the all-
trans forms. Retinal conformational change 
results in a consequent conformational change 
in the covalently bound opsin polypeptide, so 
leads to activating a second messenger 
cascade inside the photoreceptor cell that 
causes the conduction of signals to the proper 
retinal neurons. These signals are conveyed 
along the optic nerve to the visual centers of 
the brain, which allow the brain to process the 
visual input and perceive a visual image [5]. 
 
Figure 2. The structure of mammalian Rhodopsin as 
seen parallel to the plane of the membrane. [19] 
 
     Partial or full vision defect can be due to 
different conditions and diseases that destroy 
photo- receptor cells of the retina. Age-related 
Macular Degeneration (AMD) and Retinitis 
Pigmentosa (RP) are the two major diseases 
of the retina, which eventually lead to vision 
loss and blindness. In older adults AMD 
causes deterioration of both rod and cone 
photoreceptor cells of the retina, and has also 
effects on central vision. RP is an inherited 
disease with degeneration of the rod 
photoreceptor cells of the retina. Deterioration 
of the rod cells impairs the capability of 
vision in dim light and progressively 
diminishes peripheral vision, then tunnel 
vision and, finally, ends up in blindness [5 & 
6]. 
     Both AMD and RP affect a considerable 
portion of the population and primarily 
implicate the degeneration of retinal 
photoreceptor cells, whereas other neurons of 
the retina, including retinal ganglion cells 
whose long axons form the optic nerve, are  
substantially conserved [7]. 
     More improved and less surgically 
invasive retinal implants are considered 
necessary to restore at least partially the 
vision of patients suffering from retinal 
perturbation or disease of Retinitis 
Pigmentosa and Age-Related Macular 
Degeneration [5].  
     Employing a visual input that is competent 
to activate retinal ganglion cells is a 
promising method for treatment of patients 
afflicted with a photoreceptor disorder. Visual 
input activation rebuilds different degrees of 
vision. A "retina chip" or "silicon retina" is an 
electronic stimulator that activates the retinal 
ganglion cells electrically via a visual input. 
Due to the toxicity of a foreign object in the 
body, electronic stimulators are not suitable 
for clinical application. Consequently, there 
yet remains a great need for proper cure of 
these patients [7]. Thus, it is better to use a 
biomaterial to avoid of these problems.  
     BR, an identical protein to Rhodopsin of 
the retina, is a light-harvesting membrane 
protein of a halophilic arcean, Halobacterium 
salinarium  [4 and 8]. BR, Like Rhodopsins, 
is a seven α helical protein bound to the 
functional chromophore derivative of vitamin 
A (retinal) via a protonated Schiff base to a 
lysine residue. Again, like Rhodopsin, the 
natural function of BR is to operate as a light-
driven proton pump, converting sunlight into 
chemical or electric energy [4 and 9]. During 
a photo cycle of BR, the proton pumping 
occurs with photochemical conversions like 
Figure 3 [4 and 10]. Therefore, BR 
characteristics make it greatly appropriate for 
optical and photoelectric applications.  
 
 
Figure 3. BR photo cycle [4] 
 
     Under anaerobic conditions, upon light 
absorption, BR undergoes a photo cycle, by 




translocation of protons from the inside to the 
outside of the cell [11]. The electrochemical 
gradient thus generated applies for ATP 
synthesis by the cell. Based on spectral 
properties of mutants, they show absorption 
spectrum similar or different from native BR 
[12]. BR is capable to maintain the photo 
cycle even when isolated from the purple 
membrane and integrated into an artificial 
membrane, or a thin polymer-based film [1]. 
     The Japanese researchers have made a 
multilayer film coated by bacteriorhodopsin. 
These films enclose bacterial membrane onto 
a transparent tin oxide electrode hold up on a 
glass substrate. Then an aqueous electrolyte 
gel squeezes in between the membrane and a 
gold-coated glass [8]. 
     Nowadays, some prototypes of artificial 
retina apply for curing of such retinal diseases 
and conditions, but each has distinct 
disadvantages. One prototype, utilizes a diode 
of silicon to create electrical stimulation upon 
light activation. The silicon diode 
photoreceptor generates a sufficient current 
just in presence of intense light. It stimulates 
and provides only dim vision. The Artificial 
Silicon Retina (ASR) is a silicon chip 
enclosing approximately 3,500 micro 
photodiodes, each having its own stimulating 
electrode. The ASR can be surgically 
implanted under the retina and powered 
exclusively by incident light and does not 
require the external wires or batteries [6]. 
Another prototype occupies an external 
camera, mounted on a pair of eyeglasses, 
connected to a microelectrode array by a 
connecting cable. The electrode array 
provides electrical stimulation directly to the 
ganglion cells. A subject is able to perceive 
light on all electrodes of the array, detect 
motion, and recognize simple shapes. Yet, 
distinct disadvantage of this design is that it 
requires surgically implanted external 
hardware, like glasses [5]. Finally, BR 
photosensitive proteins can provide an 
efficient prototype of artificial retina for 
treating the cases. 
      The sensor made from only wild type BR, 
lacks all wavelengths and has just different 
levels of light, so black and white images can 
be perceived, but not colored. By modifying 
the BR biotechnically, the various wavelength 
responses can be produced [4]. 
      Bacteriorhodopsin films include a 
multilayer of BR proteins, in which each layer 
of the protein alternates with a layer of a 
cationic polymer. The bacteriorhodopsin 
protein is chosen from the first main layer of 
the first bacteriorhodopsin mutant and a 
second main layer of a native 
bacteriorhodopsin protein, a second 
bacteriorhodopsin mutant, or a combination 
thereof [5].  
     The steps of producing a bacteriorhodopsin 
film include; first, a layer of gold is fixed 
upon a substrate layer. Then, an individual 
layer of the first BR mutant is deposited upon 
the gold. After that, a layer of a cationic 
polymer lay down upon the individual layer 
of the gold-binding BR mutant, and additional 
alternating layers of the last and the cationic 
polymer mounted up (2-5 times) to form 
individual layers of BR mutant. Next, a layer 
of the cationic polymer lies down upon the 
last layer of the BR mutant. Now, an 
individual layer of a native BR protein, 
second bacteriorhodopsin mutant, or 
combination thereof are added upon the layer 
of the cationic polymer. Again, this last step is 
repeated until about 200 to about 400 
individual layers of the native 
bacteriorhodopsin protein, second 
bacteriorhodopsin mutant, or combination 
thereof. Thereby, BR films will be used in 
subretinal and epiretinal implants. As a result, 
providing BR mutants containing one or more 
of the amino acid substitutions is essential [5]. 
      Such films respond to illumination with 
discrepancy responsively familiar in motion 
detection, and when spatially located in the 
vertebrate eye, they can achieve edge 
enhancement [1].  
     Oriented purple membrane (PM) films 
consist of the BR-based photosensitive 
protein immobilized in an electrochemical 
photocell by means of bio affinity bonding 
with bispecific (BS) antibodies that recognize 
BR. There are methods based on this 
technology for designing intelligent 
optoelectronic devices, which contain “image 
sensors” for motion sensing, “photoreceptor 
tips” for artificial vision of human eyes, and 
“environmental sensors” for using in direction 
and speed sensing [13]. 
 
MATERIALS AND METHODS 
 
Solutions  
     PBS Buffer: 1.9 mM NaH2PO4.2H2O, 8 
mM Na2HPO4, 0.15 M NaCl. Lysis Buffer: 
Nacl 0.5 M,Tris-Hcl 20 mM pH=8.0, 
Imidazole 10 mM,0.005% PMSF. Buffer A: 
0.01 M Tris-Hcl, 0.15 M NaCl, 0.25% (w/v) 
deoxycholic acid, and 0.025% (w/v) NaN3 




titrated to pH 8.0 with NaOH. Buffer B: 0.01 
M Na2HPO4, 1% (w/v) SDS, and 0.025% 
(w/v) NaN3, pH 8.0  
 
Mutagenesis of the Synthetic bacterio-opsin 
(sbO) gene 
     Site-Directed-Mutagenesis supported with 
SOE PCR method by using the cloned vector( 
pET21a including sbO gene, considering 
E.coli codon usages, fused with parts of β-gal 
(13aa) at N-terminus, introducing an NdeI 
cloning site as the translational start and 
EcoRI site as the translational stop) as 
template and specific primers. 
Single amino acid substitutions were carried 
out by replacement of Asp85, base 294th, with 
Glu. Primer’s sequences were designed 
applying some soft ware’s and on line tools, 
represented in Table 1. First, forward primer 
corresponding to the 5  ̀ends was chosen from 
the initial of the fused gene designed to 
introduce an NdeI site (CATATG) in primer 
1. Mutagenic primers (First reverse primer, 
ER1, and second forward primer,EF2) around 
desired replacement and last reverse primers 
partly from the end of the gene adding XhoI 
site (CTCGAG) at the end of multiple cloning 
sites of the vector to obtain a cleavable C-
terminally His-tagged construct. Therefore, 
there is an NdeI restriction site at the N and an 
XhoI site at the C terminus of recombinant 
fragments. Primers sequences are presented in 
Table 1. 
 
Table 1. Primers used in current study 
primers sequences 
F1 5 َTACATATGACTATGATTACCGACTCTCTGG 3 َ
R2 5 َ  GCTCGAGTGCGGAGGTGGCAG 3 َ
ER1 5 َ GAACAGCCATTCTGCATAGCGC  3 َ  
EF2   5 َ CGCTATGCAGAATGGCTGTTCACC  3 َ
The bolded letters signify the alternated nucleotide. 
 
     Preparative plasmid (as template) isolation 
was by the protocols of Roche kit. Every PCR 
amplification consisted of: a 4µM 
concentration of each primer, a 100 µM 
concentration of mixed dNTP (Fermentas), 
2µl of template DNA, and 1 unit of Taq DNA 
polymerase (Fermentas) in a final volume of 
25µl, by timing shown in Table 2. Calibrated 
PCR procedure was repeated by Pfu DNA 
polymerase (Fermentas) for the enzyme 
fidelity. BR produced by just PCRIII and 
using primers F1 and R2. We extracted the 
PCR products by High Pure PCR Product 
Purification Kit of Bioneer (South Korea) as 
manufacturer’s manual. 
 












Bacterial Strains, Cloning and 
Transformation 
     E.coli TOP10F` (Stratagene) was 
employed as cloning host, whereas E.coli 
strain BL21 (DE3) (Novagene) served as 
expression host. The resulting PCR product 
was digested using NdeI/XhoI sites and 
inserted into the Multiple Cloning Site (MCS) 
of expression vector pET21a, which carries a 
hexa-histidine (His6) sequence at the C-
terminus. Initially, they were transformed into 
TOP10F’ subsequently, extracted plasmids 
were again transformed into DE3. 
Culture and Induction 
     Transformed BL21 (DE3) cells were 
grown at 37ºC in 5ml sterile LB Broth (from 
Scharlau) medium tubes supplemented with 
5µl Ampiciline. Upon reaching to an OD 0.6 
to 0.7 at 600nm, 10 mM IPTG (Fermentas) 
was added to induce protein synthesis. After 
an induction period of 3-4 h, the cells were 
harvested to identify and determine the level 
of expression by SDS- PAGE (Coomassie 
Blue and silver staining) Expression analyses 




PCR III PCR II PCR I 
4´ 940 940 940 Primary Denaturation 
1´ 940 940 940    Denaturation 
35 Cycle 1´ 650 660 570 Annealing 
1´ 720 720 720  Elongation 
5´ 720 720 720 Fine Extension 




Samples of protein underwent electrophoreses 
in standard SDS polyacrylamide (from 
Merck) gels (12.5% (w/v)). The gels were 
electro blotted onto nitrocellulose filters (from 
Roche) using semidry blotting (Pharmacia 
Biotech. Nova Blot) and treated with a 
monoclonal Ab, histidine-tag Ab (from 
Roche) (dilution 1:5000), as primary 
antibodies, then utilized Goat anti-mouse IgG 
conjugated (from Sigma) (dilution 1:4000), as 
secondary antibodies.  
 
Protein Expression and Purification 
     Cell cultures of interest were grown in 
large-scale batches in presence of Ampiciline 
(100µg/ml) at 37ºC and expression induced 
by addition of IPTG (10 mM) at an OD 600 of 
0.8. Cells were harvested (centrifuged at 6000 
g for 6 min at 4º C) 4 h post induction. The 
yield was ~2 g, wet weight of cells per liter of 
culture. Pellets were washed and re-suspended 
in lysis buffer (of Roche plasmid extraction 
kit). Finally, cells were disrupted by 
ultrasonication (for 40 cycles of 10 seconds) 
on ice. Membranes were collected by 
centrifugation (1 h, 20,000 g, 4 °C). Cell 
lysates were filtered using a 0.45 µm 
(Millipore) filter; then passed through pre 
packed His-Bind Columns (Novagen) as 
instruction manual protocol. The purified 
proteins` concentrations were determined 
spectrophotometrically by Bioral assay, and 
then were concentrated in a CF-25 Centricone 
to 0.5 mg/ml. The eluted protein was dialyzed 
against PBS (2 × 1 liter), at 4ºC for 1 day, by 
a dialysis tube (Mw cut-off 3500, spectrum 
Laboratories, U.S.A.). Then against buffer A 
(2 × 1 liter) at 25° C for 1 other day (sodium 
deoxycholate removes any residual cell debris 
particles), Dialysis was then continued with 
buffer B (4 × 1 liter) for 2-3 days. The 
obtained solution (BO/SDS) concentration 
was the same as before (0.5 mg/ ml). 
Lyophilized samples were stored at 4°C. 
 
Spectrometric 
     bO apoproteins were regenerated with all-
trans-retinal (from Sigma). 1mg all trans-
retinal was dissolved in 1ml ethanol which 
should be freshly prepared and kept at -20°C 
in the dark for at last two weeks. 0.2ml of 
each apoproteins was mixed to 2.5µl all-trans-
retinal solution (BO/Retinal). 
     After overnight dark adaptation, 
reconstituted BR mutants (100mg/ml), 
irradiated with light for 5min by a 200-W 
projector lamp to obtained light adapted 
variants. Spectrum analysis was assayed from 
200 to 700nm using instrument UV-Visible 




     Three SOE PCRs were done, resulting in 
desired mutants, as two pairs of primers (F1, 
xR1and xF2, R2) were employed to produce 
two separate gene fragments (300bp, 500bp) 
using the cloned sbo gene as the template. 
The resulting gene fragments were purified on 
a 1% agarose gel and served as templates for 
a third PCR reaction using the first and last 
primers (F1, R2), PCRIII produces full-length 
mutant genes (800bp) (Figure 4). All 
constructs with the desired mutations (D85E) 
were verified by DNA sequencing (Figure 5) 
and they aligned by MEGA4 soft ware 
(Figure6). 
      
Figure 4. SOE PCR results 
A; lane1; DNA ladder 100bp, Lane2; 300bp fragment (E1), Lane3; 500bp fragment (E2) 
B; lane1; DNA ladder 100bp, Lane2; 800bp fragment (D85E), Lane3; 800bp fragment (BR) 
 
 
Figure 5. DNA sequencing verified the accuracy of the point mutation 





Figure 6. Sequence alignments are showing only point mutation miss matched in mutant construct. 
 
Cloning and transformation 
Digestion of vector and PCR product with 
NdeI/XhoI and ligation were accomplished as 
mentioned. Cloned Vectors are standing upper 
comparing to blank vector, as illustrated in 
Figure 7. The accuracy of transformation is 
confirmed through NdeI/XhoI double 
digestion of fragments simultaneously. 
Sequencing of full-length plasmids confirmed 
the precision of the cloned segments in vector.  
 
Figure 7. cloned plasmids comparing to blank 




Expression of bO and D85E in E.coli (DE3), 
is initiated by culturing and induction of 
samples. Under various inductions [1–100 
mM  IPTG], they were over expressed and a 
29.6 kDa band (including; short part of  β-
gal+ bo gene+ 6His tag) was detected in 
SDS–PAGE gel shown in Figure 8, also bands 
were seen in western blots of using anti His 
tag conjugated antibodies as discerned in 





Figure 8. SDS–PAGE gel electrophoresis 
Lane 1: Molecular weight marker. Lane 2: 4h after 
induction D85E 




Figure 9. Western blot analysis by monoclonal antibody 
(anti His tag). 
 
Purification of His tagged bacterio-opsin 
His tagged bo proteins were Purified by His-
Bind Columns due to Histidine affinity to 
nickel. As shown in Figure 10. 29.6 kD 





Figure 10. SDS–PAGE gel electrophoresis detecting 
purified mutant proteins 




The absorption characteristics of BR mutants 
were analyzed using just LA (light adapted) 
forms. Variant D85E and BR exhibited peaks 
at 560 and 568 nm, respectively. In Figure 11, 





Figure 11. Absorption spectra of the BR and D85E 
(Asp85Glu) 





     Both structurally and functionally, BR is 
very similar to Rhodopsin photoreceptors of 
vertebrate [1]. While in vitro culture of 
halophilic bacteria and PM isolation are 
complicated and ineffective, protein 
production by means of genetic engineering is 
very imperative. Here, we have produced two 
types of bacteriorhodopsin, a native and a 
mutant BR (D85E) and studied their opto-
electric responses with respect to wavelength 
and absorption properties. They are 
prerequisite for designing artificial retina 
(sensors) based on biomolecules [1]. 
Therefore, the new promising technology will 
soon conceivably eradicate the blindness [6] 
by using the product of this project. 
     Improving the vision of people suffering 
from retinal disease or damage requires the 
development of retinal implants. The artificial 
retinas replace damaged photoreceptor cells, 
and thus, are capable of curing any retinal 
defects, which have not offended the bipolar 
or ganglion network [5]. 
     Mostly photo sensors, vision chips, smart 
sensors or artificial retinas, are silicon based 
[4 and 14], which has its own disadvantages. 
Light transducing photoelectric protein 
bacteriorhodopsin in artificial retinas display 
differential responsivity, motion detection and 
edge enhancement. Under appropriate 
circumstances, these artificial receptors mimic 
the differential responsivity trait of 
mammalian photoreceptor cells. Applying 
orientated bacteriorhodopsin to produce the 
photoelectrical signal allows rapid 
responsivity, and high quantum effectiveness. 
The capability of manipulating the properties 
of the protein through chemical and genetic 
methods improves devise flexibility [5]. 
     Site-directed mutagenesis of the bO gene 
was the point of our efforts to function studies 
of BR. Other prior approaches to do so, 
mutagenesis of the bO gene by techniques of 
mismatched oligo nucleotides or restriction 
fragment replacement were mostly 
ineffective. Therefore, in this work we 
improved a different approach occupying 
SOE PCR with two pairs of primers and the 
bO synthetic gene as template, introducing 
mutation in the gene in an expression vector 
to bring about a specific amino acid 
replacement. We expressed the bop gene in 
E.coli, using expression vectors that produce 
BR as fusion proteins with a segment of the 
protein of E.coli, β-gal. The expression is 
under the control of the translational signals, 
and there is the additional transcriptional 
control by the T7 promoter element 
downstream of the gene on the vector. We 
used synthetic bop gene with deletion of the 
39 nucleotide of the N-terminal leader peptide 
equal with 13 amino acids. Therefore, 
problems with inability of E.coli signal 
peptidases for removal of the leader sequence 
were solved [15]. Sequencing confirmed no 
extra mutation, except favored single site 
mutation.  
     Despite, considering E.coli codon usages 
and changing a number of codons to increase 
protein expression, it was rather low. After 
transferring to micro aerobic conditions and 
simultaneously induction was a suitable 
condition for heterologous expression of 
proteins in E.coli BL21 (DE3), which made it 
to be rather effectual for expression being 
detectable.  
     In BR production, however, the 
purification system utilized in this 
experiment, is the most efficient method, 
there are some contaminations composed of 
histidine-rich proteins of E.coli, like 
cytochromeoxidizes or aggregated bOs, which 
don`t interfere with the spectra assay [16], 
but, for applying in artificial retina, they 
should be completely purified.  
Films of multilayer bacteriorhodopsin-based 
photocell have been developed that respond to 
immediate alterations in light intensity. These 
photocells are employed to construct a 64-
pixel photoreceptor that detects moving 
images. Therefore, these films could supply 
the foundation for motion detectors or 
artificial vision apparatus [8]. 
    The reverse polarity of the photoelectric 
response of these BRs is not for structural or 
fundamental changes but due to a reverse 
orientation of recombinant proteins in 
micelles [17], this problem is solvable by 
fixing the proteins on a basis in BR films.  
     Mutant D85E and BR (WT) show up 
absorption spectra with peaks at 560 and 568 
nm, respectively. The first have blue shifts 
comparing to BR. Maximum absorption of 
recombinant proteins either the red shift or the 
blue shift are desirable and consequently have 
specific properties; they also have their own 
certain applications. For instant, they can be 
the basis of Electrochromic materials of 
different colors. 
     In spite of extensive applications in 
technologies, efforts continue towards their 
use for information processing. These proteins 
utilize as light sensitive elements in image 




detectors, artificial retina, spatial light 
modulators and holographic memories; these 
applications make BR and its mutants as a 
protein of interest. Moreover, producing 
proteins with different λmax creates a 
foundation for color sensitive sensors. 
Constructing artificial retinas based on 
bacteriorhodopsin molecules depends on color 
sensitivity developments. A sensor contains 
several proteins with different wavelength 
characteristics. 
     As a conclusion, properly oriented native 
protein is capable of producing a considerable 
ion gradient.  Thereby, the photo response and 
ion pumping properties will improve via 
genetic engineering and will develop 
performance of the retinal implant [2]. 
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